Join us at the ESMO Congress 2024 from 13-17 September in Barcelona, and discover our 2 posters on (i) the real-world usage and adverse events of immune checkpoint inhibitors, and (ii) cardiovascular toxicities in real-world cancer patients treated with immune checkpoint inhibitors.
Join us at the ESMO Congress 2024 from 13-17 September in Barcelona, and discover our 2 posters on (i) the real-world usage and adverse events of immune checkpoint inhibitors, and (ii) cardiovascular toxicities in real-world cancer patients treated with immune checkpoint inhibitors.